Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,174 | 613 | 96.1% |
| Education | $303.59 | 4 | 2.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $114.95 | 8 | 1.0% |
| Gift | $35.32 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EMD Serono, Inc. | $1,077 | 49 | $0 (2020) |
| Biohaven Pharmaceuticals, Inc. | $967.64 | 13 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $833.13 | 57 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $715.64 | 32 | $0 (2021) |
| GENZYME CORPORATION | $622.49 | 32 | $0 (2024) |
| UCB, Inc. | $592.45 | 38 | $0 (2022) |
| Biogen, Inc. | $516.62 | 34 | $0 (2021) |
| Genentech USA, Inc. | $473.43 | 34 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $326.48 | 21 | $0 (2021) |
| Grifols USA, LLC | $303.59 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $355.14 | 16 | BANNER LIFE SCIENCES, LLC ($50.43) |
| 2023 | $352.83 | 17 | SK Life Science, Inc. ($53.11) |
| 2022 | $486.25 | 23 | UCB, Inc. ($63.09) |
| 2021 | $2,252 | 97 | Biohaven Pharmaceuticals, Inc. ($945.15) |
| 2020 | $1,090 | 58 | Novartis Pharmaceuticals Corporation ($133.95) |
| 2019 | $2,720 | 151 | EMD Serono, Inc. ($514.09) |
| 2018 | $1,973 | 122 | GENZYME CORPORATION ($137.71) |
| 2017 | $2,399 | 143 | EMD Serono, Inc. ($366.27) |
All Payment Transactions
627 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: EPILEPSY | ||||||
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $30.33 | General |
| Category: Rare Disease | ||||||
| 09/27/2024 | Amneal Pharmaceuticals LLC | ONGENTYS 50MG CAPSULES 30 (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: NEUROLOGY | ||||||
| 09/13/2024 | Cycle Pharmaceuticals Inc | Tascenso ODT (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: NEUROLOGY | ||||||
| 08/30/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Immune | ||||||
| 08/16/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 07/19/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: NEUROLOGY | ||||||
| 07/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Neuroscience | ||||||
| 06/07/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $32.49 | General |
| 05/25/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Immunology and Neurology | ||||||
| 05/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Neurology | ||||||
| 03/29/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Genetic Disease | ||||||
| 03/08/2024 | BANNER LIFE SCIENCES, LLC | BAFIERTAM (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Immune | ||||||
| 01/19/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Genetic Disease | ||||||
| 01/05/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 11/10/2023 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Immunology | ||||||
| 11/03/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Genetic Disease | ||||||
| 10/27/2023 | Catalyst Pharmaceuticals, Inc. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $21.25 | General |
| Category: NEUROLOGY | ||||||
| 10/07/2023 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Immunology and Neurology | ||||||
| 09/08/2023 | Horizon Therapeutics plc | UPLIZNA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: UPLIZNA | ||||||
| 09/01/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $20.51 | General |
| 08/04/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: PAIN | ||||||
| 07/28/2023 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Genetic Disease | ||||||
| 07/22/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $32.60 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 396 | 451 | $158,054 | $36,357 |
| 2022 | 7 | 404 | 448 | $161,017 | $39,112 |
| 2021 | 11 | 1,051 | 1,217 | $357,423 | $99,928 |
| 2020 | 13 | 1,175 | 1,357 | $390,803 | $106,336 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 138 | 154 | $46,354 | $11,305 | 24.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 67 | 67 | $42,277 | $9,003 | 21.3% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 132 | 171 | $33,516 | $8,293 | 24.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 27 | 27 | $20,547 | $4,531 | 22.1% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 32 | 32 | $15,360 | $3,225 | 21.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 139 | 158 | $47,558 | $12,445 | 26.2% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 57 | 57 | $35,967 | $8,168 | 22.7% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2022 | 128 | 153 | $29,988 | $7,687 | 25.6% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 32 | 32 | $15,360 | $3,452 | 22.5% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 16 | 16 | $14,272 | $3,296 | 23.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 14 | 14 | $10,654 | $2,472 | 23.2% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 18 | 18 | $7,218 | $1,592 | 22.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 238 | 329 | $51,653 | $21,071 | 40.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 241 | 265 | $79,765 | $20,521 | 25.7% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2021 | 227 | 268 | $52,528 | $14,049 | 26.7% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 74 | 75 | $47,325 | $11,057 | 23.4% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2021 | 76 | 76 | $36,480 | $8,692 | 23.8% |
| 95911 | Nerve transmission studies, 9-10 studies | Office | 2021 | 41 | 41 | $31,201 | $7,310 | 23.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 69 | $15,939 | $6,139 | 38.5% |
| 95908 | Nerve transmission studies, 3-4 studies | Office | 2021 | 45 | 46 | $18,446 | $4,254 | 23.1% |
| 95912 | Nerve transmission studies, 11-12 studies | Office | 2021 | 14 | 14 | $12,488 | $3,028 | 24.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $8,188 | $2,637 | 32.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $3,410 | $1,169 | 34.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 272 | 381 | $59,817 | $20,210 | 33.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 229 | 254 | $76,454 | $19,136 | 25.0% |
About Dr. Robert White, M.D
Dr. Robert White, M.D is a Neurology healthcare provider based in Richmond, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396718938.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert White, M.D has received a total of $11,628 in payments from pharmaceutical and medical device companies, with $355.14 received in 2024. These payments were reported across 627 transactions from 73 companies. The most common payment nature is "Food and Beverage" ($11,174).
As a Medicare-enrolled provider, White has provided services to 3,026 Medicare beneficiaries, totaling 3,473 services with total Medicare billing of $281,733. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Richmond, VA
- Active Since 02/13/2006
- Last Updated 12/21/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1396718938
Products in Payments
- NURTEC ODT (Drug) $1,014
- Rebif (Biological) $612.53
- Briviact (Drug) $448.44
- OCREVUS (Biological) $400.13
- Mavenclad (Biological) $363.56
- APTIOM (Drug) $326.48
- AUBAGIO (Drug) $318.90
- Gamunex-C (Biological) $303.59
- ACTHAR (Biological) $292.27
- Hizentra (Biological) $248.32
- AIMOVIG (Biological) $235.02
- TROKENDI XR (Drug) $230.36
- TYSABRI (Biological) $223.03
- RYTARY (Drug) $192.46
- COPAXONE (Drug) $190.79
- GILENYA (Drug) $178.06
- SOLIRIS (Drug) $165.45
- LEMTRADA (Drug) $161.09
- KESIMPTA (Drug) $161.04
- NUPLAZID (Drug) $161.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Richmond
Catherine Ham, Md, MD
Neurology — Payments: $551,939
Dr. Daniel Hardy, M.d, M.D
Neurology — Payments: $360,216
Myla Goldman, Md, MD
Neurology — Payments: $211,301
Dr. Alan Schulman, M.d, M.D
Neurology — Payments: $171,196
Dr. Warren Felton, M.d, M.D
Neurology — Payments: $108,879
Dr. Matthew Boyce, M.d, M.D
Neurology — Payments: $103,206